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Objective: Patients with Familial Hypercholesterolemia (FH) have increased 
cardiovascular events. Clinical trials have demonstrated that lowering circulating lipid 
levels by LDL-apheresis has beneficial effects on prognosis. However, whether 
apheresis vascular effects in FH are related to modulation of pro- and anti-inflammatory 
cytokines, and whether the combination of apheresis with atorvastatin is able to 
enhance the putative anti-inflammatory effect of apheresis remains unknown. We 
examined, in a intra-patient study, the effect of atorvastatin/apheresis vs. apheresis 
alone on the releasing of circulating pro- and anti-inflammatory markers.  
Methods: 9 heterozygous patients (56+11 years) with FH (mean cholesterol 385+42 
mg/dL) were treated with apheresis alone and afterwards with apheresis plus 
atorvastatin 40 mg/d. Lipid profiles, serum C-reactive protein, CK, GOT, GGT, the anti-
inflammatory markers IL-4 and IL-10 and the pro-inflammatory markers INFγ and IL-6 
were determined before and at 2, 4, 6 and 8 days after apheresis and 
atorvastatin/apheresis.  
Results: Treatment with atorvastatin/apheresis significantly reduced lipid profile more 
than LDL-apheresis alone at each scheduled time. When compared to apheresis alone, 
combined treatment statistically decreased cholesterol by more than 25-35% at all times 
and relatively increased IL-4 concentration. The levels of cholesterol in 
atorvastatin/apheresis patients were inversely correlated with those of IL-4 and IL-10 
and positively correlated with IFNγ.  
Conclusion: The combination of atorvastatin with LDL-apheresis decreased serum 
cholesterol levels more than apheresis alone. Apheresis had an anti-inflammatory effect 
and the effect of the drug reducing cholesterol levels affects the balance between pro- 
and anti-inflammatory cytokines in favor of anti-inflammation contribute.  
